Andrew Robinson

1. Primary results from IMpassion131, a double-blind, placebo-controlled, randomised phase III trial of first-line paclitaxel with or without atezolizumab for unresectable locally advanced/metastatic triple-negative breast cancer
   2021/07/01 by David Miles, F. André, Fabrice André +242 · 3 citations
   Biochemistry, Genetics and Molecular Biology · Medicine · #Advanced Breast Cancer Therapies #Breast Cancer Treatment Studies #Cancer Immunotherapy and Biomarkers